TEVA · Teva Pharmaceutical Industries
$31.18
+3.42% last session
End-of-day data · updated 2026-07-25
Market cap
$36B
Enterprise value
$49B
Trailing P/E
23.0
Forward P/E
10.0
Dividend yield
—
Beta
0.86
Avg volume
6M
Employees
31K
2D change
-1.19%
5D change
-0.61%
10D change
-2.38%
30D change
-8.36%
60D change
-10.98%
MTD change
-7.86%
YTD change
-1.28%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — TEVA
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-28
Latest call per bank · past 12 months
Barclays
Overweight$40.00
+28.3% vs priceJP Morgan
Overweight$40.00
+28.3% vs priceUBS
Buy$42.00
+34.7% vs priceBank of America
Buy$42.00
+34.7% vs priceGoldman Sachs
Buy$45.00
+44.3% vs priceJefferies
Buy$40.00
+28.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-28 | Piper Sandler | Maintains | Overweight | $42.00 → $44.00 |
| 2026-05-06 | Barclays | Maintains | Overweight | $38.00 → $40.00 |
| 2026-04-30 | JP Morgan | Maintains | Overweight | $35.00 → $40.00 |
| 2026-04-30 | UBS | Maintains | Buy | $36.00 → $42.00 |
| 2026-04-30 | Piper Sandler | Reiterates | Overweight | $41.00 → $42.00 |
| 2026-04-30 | Truist Securities | Maintains | Buy | $42.00 → $45.00 |
| 2026-04-09 | Bank of America | Maintains | Buy | $38.00 → $42.00 |
| 2026-03-04 | Piper Sandler | Reiterates | Overweight | $40.00 → $41.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-23
- RSI (14): RSI is 42 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 7.0% below the 50-day MA ($33.52).
- Price vs 200-day MA: Trading 2.8% above the 200-day MA ($30.32).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.23) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($15.38) and high ($36.34).
TEVA Price Chart
Loading chart for TEVA…
Fundamentals
About Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE, glatiramer acetate injection to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO for the treatment of tardive dyskinesia, chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder; and ProAir RespiClick inhalation powder. It offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. The company has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. Teva Pharmaceutical Industries Limited was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
More in Drug Manufacturers - Specialty & Generic
TAK
Takeda Pharmaceutical Company L
$55B 10.6% YTD
HLN
Haleon plc
$43B -2.0% YTD
ZTS
Zoetis Inc.
$32B -39.2% YTD
UTHR
United Therapeutics Corporation
$26B 8.5% YTD
VTRS
Viatris Inc.
$20B 40.7% YTD
NBIX
Neurocrine Biosciences, Inc.
$18B 23.9% YTD
ELAN
Elanco Animal Health Incorporat
$12B 10.1% YTD
RDY
Dr. Reddy's Laboratories Ltd
$10B -16.0% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.